Diabetes mellitus secondary to glycogen storage disease type III
- PMID: 11131107
- DOI: 10.1046/j.1464-5491.2000.00378.x
Diabetes mellitus secondary to glycogen storage disease type III
Abstract
Background: Diabetes mellitus is a rare complication of glycogen storage disease type III (GSD III).
Case report: We describe a 47-year-old man with GSD III who developed diabetes mellitus. He was diagnosed as having GSD III at the age of 18 years, and his glucose tolerance was normal at that time. Liver dysfunction and muscle atrophy gradually progressed, and the patient developed diabetes mellitus at the age of 45. When the post-prandial hyperglycaemia worsened, we instituted treatment with an alpha-glucosidase inhibitor, voglibose, and this improved glycaemic control without any adverse effects.
Conclusions: We recommend serial evaluation for complications of GSD III, and propose that an alpha-glucosidase inhibitor may be a favourable drug in treating diabetes mellitus secondary to GSD III.
Similar articles
-
Prevention of hypoglycaemia in a patient with type Ib glycogen storage disease by an amylase (alpha-glucosidase) inhibitor.Acta Paediatr. 1998 May;87(5):595-8. doi: 10.1080/08035259850158362. Acta Paediatr. 1998. PMID: 9641747
-
[Effects of voglibose, alpha-glucosidase inhibitor in treatment of impaired glucose tolerance].Nihon Rinsho. 2005 Feb;63 Suppl 2:457-61. Nihon Rinsho. 2005. PMID: 15779422 Review. Japanese. No abstract available.
-
Insulin secretion levels necessary for efficacy of an alpha-glucosidase inhibitor on glucose metabolism in patients with non-insulin-dependent diabetes mellitus.J Int Med Res. 1995 Nov-Dec;23(6):497-501. doi: 10.1177/030006059502300613. J Int Med Res. 1995. PMID: 8746619
-
Effect of an alpha-glucosidase inhibitor (voglibose), in combination with sulphonylureas, on glycaemic control in type 2 diabetes patients.J Int Med Res. 1998 Oct-Nov;26(5):219-32. doi: 10.1177/030006059802600501. J Int Med Res. 1998. PMID: 9924706 Clinical Trial.
-
[Efficacy of combination therapy of alpha-glucosidase inhibitor and insulin sensitizer in patients with type 2 diabetes].Nihon Rinsho. 2002 Sep;60 Suppl 9:464-9. Nihon Rinsho. 2002. PMID: 12387035 Review. Japanese. No abstract available.
Cited by
-
Hormonal dysfunction in adult patients affected with inherited metabolic disorders.J Mother Child. 2020 Nov 10;24(2):21-31. doi: 10.34763/jmotherandchild.20202402si.2018.000005. J Mother Child. 2020. PMID: 33179602 Free PMC article. Review.
-
Endocrine manifestations related to inherited metabolic diseases in adults.Orphanet J Rare Dis. 2012 Jan 28;7:11. doi: 10.1186/1750-1172-7-11. Orphanet J Rare Dis. 2012. PMID: 22284844 Free PMC article. Review.
-
Role of continuous glucose monitoring in the management of glycogen storage disorders.J Inherit Metab Dis. 2018 Nov;41(6):917-927. doi: 10.1007/s10545-018-0200-5. Epub 2018 May 25. J Inherit Metab Dis. 2018. PMID: 29802555
-
Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome.J Inherit Metab Dis. 2016 Sep;39(5):697-704. doi: 10.1007/s10545-016-9932-2. Epub 2016 Apr 22. J Inherit Metab Dis. 2016. PMID: 27106217 Free PMC article.
-
A retrospective longitudinal study and comprehensive review of adult patients with glycogen storage disease type III.Mol Genet Metab Rep. 2021 Nov 11;29:100821. doi: 10.1016/j.ymgmr.2021.100821. eCollection 2021 Dec. Mol Genet Metab Rep. 2021. PMID: 34820282 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical